title: Activation of cultured rat hepatic stellate cells by tumoral hepatocytes.
abstract: Hepatocellular carcinoma (HCC) is the main type of primary liver cancer, and it develops from hepatocytes. The stroma of HCC is infiltrated by myofibroblasts. In other settings, such as liver fibrosis, myofibroblasts are derived mainly from the activation of hepatic stellate cells (HSC). In this study, we investigated whether tumoral hepatocytes were able to activate HSC. HSC were isolated from normal rats and were plated in dishes coated with Matrigel, to prevent their spontaneous activation. HSC were exposed to conditioned medium (CM) from the rat HCC lines Fao and H5. Tumor cell CM elicited major morphologic changes, such as spreading and generation of cytoplasmic processes. Fao and H5 CM increased HSC proliferation to 1.60 and 1.76 times control values, respectively. The expression of alpha-smooth muscle actin was low or undetectable in control cells and was markedly increased by both tumor cell CM but not by normal rat hepatocyte CM. Desmin expression was also enhanced. Gelatinase A secretion was significantly increased 1.20-fold by Fao CM and 1.55-fold by H5 CM. Expression of beta-type platelet-derived growth factor receptor mRNA was increased 5.8-fold by H5 CM but was decreased to 13% of control levels by Fao CM. HSC activation by tumor cell CM was not prevented by urokinase or matrix metalloproteinase inhibitors, suggesting that Matrigel degradation was not central to the activation process. Finally, a blocking antibody to transforming growth factor-beta1 did not impede Fao CM-induced activation but significantly blocked the increase in matrix metalloproteinase-2 expression induced by H5 CM. Our results show that tumoral rat hepatocyte CM is able to induce the activation of rat HSC in culture. The lack of induction of beta-type platelet-derived growth factor receptor mRNA by Fao CM indicates that, in some cases, tumor-induced activation differs from classic fibrosis-type activation. Our data thus suggest that HSC recruitment and activation in HCC could be under the control of tumor cells.
authors.affiliation: Groupe de Recherches pour l'Etude du Foie, Université Victor Segalen Bordeaux 2, France.
authors.forename: S
authors.initials: S
authors.lastname: Faouzi
authors.forename: S
authors.initials: S
authors.lastname: Lepreux
authors.forename: C
authors.initials: C
authors.lastname: Bedin
authors.forename: L
authors.initials: L
authors.lastname: Dubuisson
authors.forename: C
authors.initials: C
authors.lastname: Balabaud
authors.forename: P
authors.initials: P
authors.lastname: Bioulac-Sage
authors.forename: A
authors.initials: A
authors.lastname: Desmoulière
authors.forename: J
authors.initials: J
authors.lastname: Rosenbaum
mesh_terms: D000818:Animals; D002455:Cell Division; D002478:Cells, Cultured; D018920:Coculture Techniques; D017077:Culture Media, Conditioned; D003893:Desmin / Q000235:genetics; D018093:Gelatinases / Q000378:metabolism; D008099:Liver / Q000166:cytology* / Q000502:physiology*; D008114:Liver Neoplasms, Experimental / Q000473:pathology* / Q000503:physiopathology*; D008297:Male; D020778:Matrix Metalloproteinase 2; D008666:Metalloendopeptidases / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D020797:Receptor, Platelet-Derived Growth Factor beta; D017479:Receptors, Platelet-Derived Growth Factor / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014158:Transcription, Genetic; D016212:Transforming Growth Factor beta / Q000502:physiology; D014407:Tumor Cells, Cultured
chemical_list: D017077:Culture Media, Conditioned; D003893:Desmin; D012333:RNA, Messenger; D016212:Transforming Growth Factor beta; D020797:Receptor, Platelet-Derived Growth Factor beta; D017479:Receptors, Platelet-Derived Growth Factor; D018093:Gelatinases; D008666:Metalloendopeptidases; D020778:Matrix Metalloproteinase 2